Anticancer effects of Withaferin A and its ability to modulate TGF-β signaling were investigated in human endometrial cancer where the results found G2/M cell cycle arrest and apoptosis of human KLE endometrial cancer cells (Xu et al., 2021). This evidence concerns the gene TGFB1 and endometrial cancer.